Our history

Ceres Pharma intends to grow by developing its own portfolio and through acquisitions.

2019
2018
August

Acquisition of Mithra generic gynaecologic products

TURNOVER >20.000 K
2017
June

Consolidation of Pharco Innovations, CalxPlus, Primrose & Etixx to Ceres Pharma

Turnover: >12.000 K
2017
January

Acquisition of Etixx Sports Nutrition

TURNOVER: 8.700K
2016
July

Acquisition of Primrose

Turnover: >3.750K
2016
February

Acquisition of CalxPlus

2015
October

Acquisition of Pharco